PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.35%
Revenue decline while CRK shows 28.87% growth. Joel Greenblatt would examine competitive position erosion.
1.37%
Cost growth less than half of CRK's 29.59%. David Dodd would verify if cost advantage is structural.
-31.93%
Gross profit decline while CRK shows 27.69% growth. Joel Greenblatt would examine competitive position.
-18.62%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
-95.62%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-64.76%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-27.57%
Total costs reduction while CRK shows 26.66% growth. Joel Greenblatt would examine advantage.
-2.02%
Interest expense reduction while CRK shows 6.06% growth. Joel Greenblatt would examine advantage.
2.94%
D&A growth less than half of CRK's 39.37%. David Dodd would verify if efficiency is sustainable.
-30.18%
EBITDA decline while CRK shows 64.68% growth. Joel Greenblatt would examine position.
90.34%
EBITDA margin growth exceeding 1.5x CRK's 5.87%. David Dodd would verify competitive advantages.
-108.89%
Operating income decline while CRK shows 33.16% growth. Joel Greenblatt would examine position.
-110.63%
Operating margin decline while CRK shows 3.33% growth. Joel Greenblatt would examine position.
67.48%
Other expenses growth 1.25-1.5x CRK's 48.35%. Martin Whitman would scrutinize cost items.
-135.42%
Pre-tax income decline while CRK shows 536.74% growth. Joel Greenblatt would examine position.
-142.34%
Pre-tax margin decline while CRK shows 394.08% growth. Joel Greenblatt would examine position.
-244.19%
Tax expense reduction while CRK shows 228.05% growth. Joel Greenblatt would examine advantage.
-104.03%
Net income decline while CRK shows 711.60% growth. Joel Greenblatt would examine position.
-104.81%
Net margin decline while CRK shows 529.77% growth. Joel Greenblatt would examine position.
-104.13%
EPS decline while CRK shows 632.32% growth. Joel Greenblatt would examine position.
-104.05%
Diluted EPS decline while CRK shows 379.80% growth. Joel Greenblatt would examine position.
-1.85%
Share count reduction while CRK shows 9.21% change. Joel Greenblatt would examine strategy.
-0.02%
Diluted share reduction while CRK shows 65.67% change. Joel Greenblatt would examine strategy.